Pfizer Shares Rise Even as U.S. Lawmakers, Administration Criticize Drug Pricing

Pfizer Shares Rise Even as U.S. Lawmakers, Administration Criticize Drug Pricing


President Trump may not have tweeted at Pfizer yet, but that doesn't mean that government voices have been quiet on drug pricing. Shares of the New York City-based pharmaceutical giant are rising on Monday, shaking free of concerns over drug price raising and marching back toward "business as normal."



from Biotech News